Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with

Gavin A Lewis1,2, Anna Rosala-Hallas3, Susanna Dodd4

  • 1Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Insights

Antifibrotic therapy improved heart failure symptoms, but regression of myocardial fibrosis did not significantly improve left ventricular ejection fraction (LVEF) in patients with heart failure with preserved ejection fraction (HFpEF).

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Translational Medicine

Background:

  • Myocardial fibrosis is linked to poor outcomes in heart failure with preserved ejection fraction (HFpEF).
  • The precise mechanisms by which fibrosis impacts cardiovascular function in HFpEF remain incompletely understood.

Purpose of the Study:

  • To investigate if regression of myocardial fibrosis mediates improvements in cardiovascular function and functional status after antifibrotic therapy.
  • To analyze the causal mediation effects of fibrosis components on left ventricular ejection fraction (LVEF) in HFpEF patients.

Main Methods:

  • Mediation analyses were conducted on data from the Pirfenidone in Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction (PIROUETTE) trial.
  • Cardiovascular magnetic resonance extracellular volume (ECV) was used to measure myocardial fibrosis.

Main Results:

  • Regression of myocardial fibrosis correlated with enhanced 6-minute walk test performance and KCCQ clinical summary scores.
  • Left ventricular ejection fraction (LVEF) showed a treatment effect, increasing post-therapy.
  • No significant causal mediation effects were found for myocardial ECV, extracellular matrix volume, or cellular volume on LVEF.

Conclusions:

  • While antifibrotic therapy shows benefits in HFpEF functional status, myocardial fibrosis regression does not appear to be the primary mediator of LVEF improvement.
  • Further research is needed to elucidate the mechanisms linking fibrosis to adverse outcomes and therapeutic responses in HFpEF.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
46
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27